morning all, just skimming through and seen snippets of comments...

morning all, just skimming through and seen snippets of comments with biotron in the past having high cash burn through the years, just a thought but did they not mention that the money should last them quite some time as they will be focusing on commercialism with there compounds so there won't be high cash burn till they re-enter trials for hep-b wIth JV/partner. along with high interest with our hep-c we could see 250m-600m maybe some royalties maybe not. but with that we would be half way too our MC goal 2$ or 1B?, along with possible new LT investers and/or more Instos after the data release. is this correct or am I misinterpreting? cheers